Evidence review

VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-gabapentin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-gabapentin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-gabapentin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-gabapentin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-gabapentin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-gabapentin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Gabapentin / pregabalin

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.4 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Vasoactive intestinal peptide (VIP) prevents experimental arthritis (source s5)

Summary of mouse collagen-induced arthritis study with VIP treatment.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Effect of Vasoactive Intestinal Polypeptide on Development of Headache and Associated Symptoms (source s11)

Human RCT on VIP infusion effects in volunteers.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension (source s16)

Human measurement of VIP levels in disease vs controls.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Gabapentin · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 4 sources · swipe →chain 560971eff23a · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
preclinical
VIP reduces incidence and severity of collagen-induced arthritis in mice via inflammatory mediator suppression.
sources: s5
preclinical
VIP shows anti-inflammatory effects in mouse arthritis models but no direct human neuropathic pain trials exist.
sources: s5
mechanistic
Gabapentin and pregabalin inhibit α2δ subunit-containing voltage-dependent calcium channels.
sources: s28
humanlow confidence
A randomized trial showed VIP infusion produces modest cranial hemodynamic effects in healthy volunteers.
sources: s11
humanlow confidence
Lower VIP levels observed in primary pulmonary hypertension patients versus controls.
sources: s16
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:31
VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Gabapentin
Slug: vip-gabapentin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Gabapentin / pregabalin","condition_key":"gabapentin-lyrica","primary_peptide":"vip","peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaki
it output
{
  "slug": "vip-gabapentin",
  "title": "VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers",
  "body": "## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin primarily act on voltage-gated calcium channels to reduce excitatory neurotransmitter release. This leads to dampened nerve signaling in conditions involving neuropathic pain or hyperexcitability. The drug suppresses pain signals without addressing underlying nerve tissue integrity or inflammatory states that may contribute to ongoing issues. If autonomic regulation or immune balance plays a role in your experience with these medications, that layer remains unaddressed by the drug itself.\n\nDegeneration here centers on sustained nerve hyperexcitability and potential secondary inflammatory contributions rather than direct mechanical breakdown. Repair pathways would focus on modulating immune responses and autonomic tone to support tissue homeostasis instead of ongoing signal suppression.\n\n## Why VIP might help you\n\n1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP acts on VPAC1 and VPAC2 receptors expressed in immune cells and autonomic nerves. This binding can shi
de3b5d999b5e5ec6
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "VIP reduces incidence and severity of collagen-induced arthritis in mice via inflammatory mediator suppression."?
ask vip-gabapentin claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP shows anti-inflammatory effects in mouse arthritis models but no direct human neuropathic pain trials exist."?
ask vip-gabapentin claim c5 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Gabapentin and pregabalin inhibit α2δ subunit-containing voltage-dependent calcium channels."?
ask vip-gabapentin claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "A randomized trial showed VIP infusion produces modest cranial hemodynamic effects in healthy volunteers."?
ask vip-gabapentin claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Lower VIP levels observed in primary pulmonary hypertension patients versus controls."?
ask vip-gabapentin claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers — and what would you need me to tell you first?
ask vip-gabapentin condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP Peptide Evidence for Gabapentin Users: Immune and Autonomic Layers (studies vs anecdotes)?
ask vip-gabapentin good bad experiences · paste includes §SELF
vip-gabapentin · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 29423 tokens · $0 · 1 model
chain head 0a359f8493ed9ba3
write grok/grok-4.3 · 2026-06-29 22:31 · 29423 tok · 0a359f8493ed
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 22:32
webhook_in blooio · 2026-06-29 22:32
PROTOCOL_RUN dispatch · 2026-06-29 22:32 · t_gbmobk6a
PROTOCOL_RUN dispatch · 2026-06-29 22:32 · t_gbmobk6a
webhook_in blooio · 2026-06-29 22:32
webhook_in blooio · 2026-06-29 22:31
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-gabapentin · GET /api/articles/vip-gabapentin?format=post (the editable body)
create/replace POST /api/articles/vip-gabapentin · PUT /api/articles/vip-gabapentin (replace, keeps revision) · PATCH /api/articles/vip-gabapentin (merge)
delete DELETE /api/articles/vip-gabapentin
writes need header x-terminal-key
LLM bundle GET /api/articles/vip-gabapentin/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim vip-gabapentin|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →